Xiaohong Chen

Title: Inventor Spotlight: Xiaohong Chen

Introduction

Xiaohong Chen is a notable inventor based in Broomfield, Colorado, recognized for his contributions in the field of pharmaceuticals. With a substantial portfolio of patents, Chen has focused on significant innovations that hold promise for treating various diseases.

Latest Patents

Chen holds two patents, with his latest invention centering on allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K). This invention describes compounds of Formula (I) that can serve as allosteric chromenone inhibitors targeting PI3K, thereby being beneficial in the treatment of diseases or disorders linked to the modulation of PI3K. These compounds, alongside their pharmaceutically acceptable salts, are part of a broader disclosure that also includes methods for their preparation and application.

Career Highlights

Currently, Chen is associated with Petra Pharma Corporation, a company engaged in innovative pharmaceutical research. His work has played a crucial role in advancing the understanding and development of therapies that leverage PI3K modulation. The impact of his inventions is significant, potentially leading to new treatments for various health conditions.

Collaborations

Throughout his career, Xiaohong Chen has collaborated with talented colleagues, including Erin Danielle Anderson and Sean Douglas Aronow. These partnerships enhance the collaborative culture at Petra Pharma Corporation and foster innovation in their research efforts.

Conclusion

Xiaohong Chen's dedication to innovation in pharmaceutical science is evident through his patent filings and collaborations. With ongoing research and development, his work continues to contribute to advancements in medical treatments, showcasing the impact inventors can have on society. As the field of pharmacology evolves, innovators like Chen remain at the forefront of creating solutions that address pressing health challenges.